Mineral & Financial Investments Limited
GEORGE TOWN CAYMAN ISLANDS, October 1, 2020 - Mineral and Financial Investments Limited (LSE-AIM: MAFL) ("M&FI") announces changes to its board of directors.
Mr. James Lesser will step back from his role as Chief Operating Officer of M&FI. However, Mr. Lesser has agreed to remain on the M&FI Board and continue to be an integral part of M&FI's governance, accordingly he will be appointed Non-Executive Director of the Company with immediate effect. Over the past several months Mr Lesser's time commitment advising international and supranational organisations has grown and impinged on his time availability for M&FI matters.
Jacques Vaillancourt, Executive Chairman of M&FI said "Jamie is a great colleague and a highly professional team player whose daily contributions will be missed. However, we are delighted and thankful that Jamie will remain on the M&FI Board and we will continue to benefit from his wise counsel. Jamie will be available for specific issues where his various talents can be used."
FOR MORE INFORMATION:
Jacques Vaillancourt, Mineral & Financial Investments Ltd. +44 780 226 8247
Katy Mitchell, WH Ireland Limited +44 161 832 2174
Jon Belliss, Novum Securities Limited +44 207 399 9400
Dominic Baretto, Yellow Jersey PR Limited +44 203 004 9512
ABOUT MINERAL AND FINANCIAL INVESTMENTS LIMITED:
Mineral and Financial Investments Limited is a Swiss and Cayman Island based investment company quoted on AIM, a market of the London Stock Exchange. M&FI has in excess of 20 investments in the natural resource sector with the majority in the metals and minerals sector and has about 38% of its investment portfolio in precious metal investments. M&FI's Net Asset Value per share (NAVPS)is 15.11p, as of March 31, 2020. M&FI's NAVPS has risen at a Compound Annual Growth Rate (CAGR) of 31.2% since December 31, 2016.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact email@example.com
or visit www.rns.com